ABSTRACT Ventilation and gas exchange during overnight sleep was studied in a group of seven patients with severe interstitial lung disease (mean vital capacity 50%, mean diffusing capacity 46% predicted), to see whether clinically significant oxygen desaturation occurred. Patients with a history of loud snoring or clinically significant airflow obstruction were excluded. Sleep was fragmented in these patients, but all achieved rapid eye movement (REM) sleep. All patients showed episodes of oxygen desaturation during sleep-mean (SEM) awake arterial oxygen saturation (Sao2) was 92 9% (0 3%) compared with a mean minimum Sao2 during sleep of 83X2% (2-1%) (p < 0-01). These episodes were, however, transient, and mean Sao2 showed only a slight fall between wakefulness and sleep (non-REM 91-5%, REM 90-4%; NS). Furthermore, Sao2 during non-REM sleep correlated well (p < 0X001) with Sao2 during wakefulness. Respiratory frequency showed a significant fall between wakefulness and sleep-21 1 (1 8) versus 17-3 (1.5) breaths per minute (p < 0 02). Our data suggest that nocturnal oxygen treatment need not be considered in patients with interstitial lung disease unless the level of oxygenation while they are awake indicates the need for such treatment.
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Patients with chronic obstructive lung disease may develop periods of profound oxygen desaturation during sleep, particularly during rapid eye movement (REM) sleep.'1 -This desaturation may be associated with serious cardiac arrhythmias,3 and may be an important determinant in the development of cor pulmonale in such patients. 4 Furthermore, these nocturnal abnormalities may predispose to sudden death. 5 Two recent studies have suggested that serious oxygen desaturation may occur in patients with interstitial lung disease.6 7 Both of these studies, however, included patients who snored, and one6 included patients with sleep apnoea. Since both of these factors can produce oxygen desaturation during sleep, such inclusions may have influenced the results. The question has important practical implications because of the documented benefits of supplemental nocturnal oxygen treatment in patients with chronic obstructive lung disease who show desaturation during sleep.3 89 If serious oxygen desaturation during sleep is a common feature in patients with interstitial lung disease, supplemental nocturnal oxygen treatment might need to be considered.
We have therefore measured ventilation and oxygenation during sleep in a group of patients with severe interstitial lung disease, specifically excluding patients with a history of loud snoring or with appreciable airflow obstruction.
Methods
We studied seven men with previously diagnosed interstitial lung disease. None had a history of loud snoring or daytime hypersomnolence and none had clinically significant airflow obstruction, although two patients had a slightly reduced FEV1/FVC ratio.
Details are given in table 1.
All patients underwent at least one overnight sleep study, and two patients underwent two separate studies. All sleep studies were performed with standard polysomnographic techniques,10 which included continuous recording of electroencephalogram (C4/AI and C3/A1 electrode positions), right and left electrooculogram, and submental electromyogram, all from surface electrodes. Ventilation was measured noninvasively using a respiratory inductance plethysmograph (Respitrace), which was calibrated by the least squares method.1 This device, when calibrated Fibrosing alveolitis  69  60  84  87  24  9 4  5 0   7-46  2  46  Farmer's lung  44  39  88  74  59  9-9  6-3  7 41  3  62  Fibrosing alveolitis  49  48  77  75  52  8-4  4-7  7-45  4  62  Fibrosing alveolitis  70  72  72  83  32  8 1  5-1   7-43  5  56  Farmer'slung  51  44  89  71  46  10-1  6-3  741  6  62  Fibrosing alveolitis  62  54  84  83  82  113  4-5   7-45  7  61  Fibrosing alveolitis  45  36  94  87  30  5 8  5-2  7 50  Mean  59  56  50  84  80  46  9-0  5 Respiratory frequency showed a significant fall be- Heavy snorers were specifically excluded from our study, although one patient was unexpectedly found to have a small number of episodes of obstructive apnoea during sleep. These episodes, however, were associated with only a minor degree of oxygen desaturation. Perez-Padilla et al also reported significant desaturation, particularly during REM sleep, in their patients with interstitial lung disease, but again most of their patients snored. It is, however, apparent from their data that mean Sao2 showed only a small fall during the various sleep stages, similar to our findings. The difference in degree of oxygen desaturation during sleep between our patients and those reported by Bye et al and Perez-Padilla et al cannot be explained by differences in oxygenation during wakefulness since our patients had a lower mean arterial Po2 during wakefulness than those of Bye et al, and had values similar to those of the patients of Perez-Padilla etal.
Hypoxaemic patients with interstitial lung disease would not necessarily be expected to show changes in oxygenation during sleep similar to those found in patients with chronic obstructive lung disease with equivalent levels of hypoxaemia. The hypoxaemia seen during sleep, particularly REM sleep, in patients with chronic obstructive lung disease has a multifactorial basis,2 [14] [15] [16] related to changes in respiratory drive, changes in functional residual capacity of the lung, inhibition of accessory muscles of respiration, and impaired function of the diaphragm related to hyperinflation. Some of these factors-for example, impaired diaphragm function-would not apply in patients with interstitial lung disease.
Patients with interstitial lung disease typically have a rapid shallow breathing pattern during wakefulness, which is likely to be a vagally mediated response to decreased lung compliance. ' 
